Children's Health Defense By
The 440 lawsuits brought against Tylenol and generic acetaminophen manufacturers do not have “admissible evidence” to show that prenatal exposure to the medication can lead to autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD), a federal judge ruled this week.
The news comes as a blow to the hundreds of families who filed lawsuits alleging their child developed ASD and/or ADHD as a result of the mother taking acetaminophen during the pregnancy.
U.S. District Judge Denise Cote in the Southern District of New York, who is presiding over the cases, in her 148-page opinion wrote that, in the absence of admissible evidence, the District Court will not hear the plaintiff’s expert testimony.
The ruling “effectively kills” the consolidation of lawsuits, Bloomberg reported. The Defender asked lawyers with four of the main firms handling the cases for comment, but they did not respond by our publication deadline.
The lawsuits allege retailers, including Walmart, CVS, Walgreens and others, falsely advertised products that contain acetaminophen as being safe for pregnant women and did not warn them about the risks posed to fetal development.
Johnson & Johnson’s former consumer health unit, now a separate company called Kenvue, told Reuters in a statement it will move to dismiss the lawsuits in light of the ruling. Johnson & Johnson, the original maker of the Tylenol brand, was not named in the suits…
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
